Epcoritamab (Epkinly), a novel bispecific antibody to target cancer cells
3:32
Epcoritamab (Epkinly), a novel bispecific antibody to target cancer cells
909 viewsJun 16, 2023
YouTubeDoses of Videos
FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles
21:32
FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles
5.9K views10 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discussions
Introducing the Phase III EPCORE FL-1 trial: epcoritamab plus R2 versus R2 for R/R FL
3:07
Introducing the Phase III EPCORE FL-1 trial: epcoritamab plus R2 versus R2 for R/R FL
134 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Primary results from the Phase III EPCORE FL-1 trial: epcoritamab plus R2 versus R2 for R/R FL
5:28
Primary results from the Phase III EPCORE FL-1 trial: epcoritamab plus R2 versus R2 for R/R FL
103 views8 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
EHA 2025 | How effective is epcoritamab + R-ICE in patients with R/R DLBCL who are ASCT eligible?
1:52
EHA 2025 | How effective is epcoritamab + R-ICE in patients with R/R DLBCL who are ASCT eligible?
388 viewsJun 17, 2025
YouTubeLymphoma Hub
¡China aprueba Epcoritamab para el tratamiento del linfoma! 🇨🇳🧬
0:47
¡China aprueba Epcoritamab para el tratamiento del linfoma! 🇨🇳🧬
216 views4 months ago
YouTubeDengYue
ASH 2025 | EPCORE FL-1 phase III primary results: Epcoritamab + R2 vs R2 alone for R/R FL
1:36
ASH 2025 | EPCORE FL-1 phase III primary results: Epcoritamab + R2 vs R2 alone for R/R FL
373 views9 months ago
YouTubeLymphoma Hub
1:37
Epcoritamab monotherapy in first-line Richter’s transformation: 2-year follow-up of EPCORE CLL-1
113 viewsSep 16, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
3:09
The role of epcoritamab in third-line or later LBCL
1.1K viewsJul 28, 2023
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:53
Epcoritamab + R2 or epcoritamab maintenance in 1L FL: 3-year outcomes from EPCORE NHL-2 arms 6 & 7
47 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
1:25
Guidance on the use of epcoritamab for the treatment of follicular lymphoma
127 viewsJun 18, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:58
Fixed-duration epcoritamab in older patients with newly diagnosed DLBCL and comorbidities
61 views10 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
3:55
Can Epcoritamab Improve Outcomes in R-mini-CHOP Patients? #DLBCL | Chan Cheah, MD, PhD | #ASH25
129 views9 months ago
YouTubeHealthTree Foundation for Leukemia
1:29
Two-year follow-up results from EPCORE CLL-1: epcoritamab monotherapy in Richter's transformation
71 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
10:07
Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicul...
22 views5 months ago
YouTubeecancer
5:31
Advances in Lymphoma From ASH 2025: EPCORE FL-1, Epcoritamab Combination, and Beyound
1.1K views8 months ago
YouTubeOncUpdates: Latest Oncology Insights
3:13
Safety and efficacy of epcoritamab + R-CHOP in patients with DLBCL & high-risk features
304 viewsJul 8, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
1:39
Fixed-duration epcoritamab with BR for 1L treatment of FL: 3-year results from EPCORE NHL-2 arm 3
28 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
5:53
ASH 2025 | EPCORE FL-1 phase III primary results: Epcoritamab + R2 vs R2 alone for R/R FL
250 views9 months ago
YouTubeLymphoma Hub
2:23
Fixed-duration epcoritamab + R-CHOP in newly diagnosed higher-risk DLBCL: follow-up of EPCORE NHL-2
37 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
0:59
Dr Leslie on Epcoritamab Plus Lenalidomide and Rituximab in Follicular Lymphoma
122 views9 months ago
YouTubeOncLive
1:14
Interim analysis of a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL
38 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:15
Long-term disease control associated with epcoritamab and CAR T-cell therapy in LBCL
65 views10 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
3:56
EPCORE NHL-2: epcoritamab + intensive chemotherapy in patients with R/R DLBCL eligible for autoSCT
96 viewsSep 30, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
6:28
ctDNA-directed epcoritamab ± R2 in LBCL at high risk of relapse post-CAR-T: Phase II EpLCART trial
133 viewsJun 30, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
4:07
Epkinly (Epcoritamab) how to use: Uses, Dosage, Side Effects, Contraindications
1K viewsJun 13, 2023
YouTubePharmacy Assistant
1:04
Insights into the potential value of epcoritamab in third-line DLBCL & FL
42 viewsSep 11, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
1:24
Bringing epcoritamab into earlier lines of therapy for DLBCL
31 views11 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:19
A Phase II trial evaluating rituximab and epcoritamab as first-line therapy for high-tumor burden FL
339 viewsJun 23, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
1:50
Managing the adverse events associated with epcoritamab treatment: focus on CRS
172 viewsJan 6, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
See more
Static thumbnail place holder